These 5 Dallas Tech Companies Raised the Most Funding in June

Learn how the companies who raised last month’s largest rounds are investing their new capital.

Written by Jeff Rumage
Published on Jul. 06, 2022
These 5 Dallas Tech Companies Raised the Most Funding in June
dallas skyline
Photo: Shutterstock

VC funding provided a boost to a wide variety of Dallas–Fort Worth companies in June. The top five funding rounds, which totaled a collective $198.3 million, helped accelerate the growth of companies in biotech, Web3 gaming and virtual wedding planning services, to name a few. Read on to find out which companies raised funds and how they plan to use their fresh capital.


#5. $1.3 million, June 15

Fêtefully is an online wedding planning service that helps couples build a budget, manage their guest list, pick a venue and navigate the world of wedding vendors. Last month’s $1.3 million funding round brought the company’s total funding raised to $2.6 million. Founder and CEO GiGi McDowell is one of 98 Black women founders to raise more than $1 million in venture funding.


#4. $14.5 million, June 2

Sanara MedTech raised $14.5 million, according to documents filed with the SEC on June 2. The Fort Worth-based company develops products and technologies that healthcare providers use for wound care and surgical tissue repair.


#3. $16.5 million, June 15

Nacuity Pharmaceuticals is a biopharmaceutical company developing treatments for eye diseases caused by oxidative stress, such as cataracts and retinitis pigmentosa. The company’s $16.5 million Series B round was led by Foundation Fighting Blindness and its venture arm RD Fund. The funding will be used to support the company’s upcoming clinical trials.


#2. $46 million, June 14

The Wildcard Alliance is a subsidiary of McKinney-based Playful Studios. The new subsidiary raised $46 million to launch a new Web3 gaming franchise called Wildcard, which is described in a news release as a hybrid of multiplayer online battle arena, real-time strategy and collectible card game where players compete surrounded by live, interactive fans and spectators. 


 #1. $120 million, June 29

ReCode Therapeutics, which is dual headquartered in Dallas and Menlo Park, California, added another $120 million to its $80 million Series B round from last year, bringing its total Series B funding to $200 million. ReCode, which has developed disease-modifying mRNA and gene correction therapeutics, is able to precisely target organs and cells beyond the liver with its selective-organ-targeting lipid nanoparticle platform. The company’s lead programs are focused on primary ciliary dyskinesia and cystic fibrosis. ReCode was among the first DFW biotech companies to join Biotech+, a 40,000-square-foot co-working lab and office space that opened in March.

Hiring Now
Machine Learning • Mobile • Other • Social Impact • Software • App development